Key Takeaways
- • Consonance Capital Partners closed Consonance Private Equity III with $1.35bn in commitments, reaching its hard cap.
- • The fundraise was oversubscribed and completed in less than four months.
- • The fund will target lower and middle-market healthcare businesses in the US, continuing its predecessor funds' strategy.
- • Investors include endowments and foundations, pension plans and financial institutions from global markets, with a mix of existing and new limited partners.
- • Monument Group served as global placement agent and Latham & Watkins as legal counsel.
Summary
Healthcare-focused private investment firm Consonance Capital Partners has closed its third private equity fund, Consonance Private Equity III, with $1.35bn in commitments, according to the firm's announcement. The fund reached its hard cap following an oversubscribed fundraising process that took less than four months.
The fund will target lower and middle-market healthcare businesses in the United States, continuing the investment strategy used by the firm's predecessor funds. Its investment approach spans growth equity, leveraged buyouts, corporate carve-outs, recapitalisations and special situations. The firm focuses on businesses seeking to improve healthcare efficiency, control costs and deliver high-quality patient care.
The fund attracted substantial backing from existing limited partners alongside a select group of new investors. Its investor base includes endowments and foundations, pension plans and financial institutions from across global markets. Consonance said the outcome reflected investor confidence in its team, investment strategy and track record, as well as established relationships with its limited partners and portfolio company management teams.
Monument Group acted as global placement agent for the fund, while Latham & Watkins served as legal counsel.
The fund will target lower and middle-market healthcare businesses in the United States, continuing the investment strategy used by the firm's predecessor funds. Its investment approach spans growth equity, leveraged buyouts, corporate carve-outs, recapitalisations and special situations. The firm focuses on businesses seeking to improve healthcare efficiency, control costs and deliver high-quality patient care.
The fund attracted substantial backing from existing limited partners alongside a select group of new investors. Its investor base includes endowments and foundations, pension plans and financial institutions from across global markets. Consonance said the outcome reflected investor confidence in its team, investment strategy and track record, as well as established relationships with its limited partners and portfolio company management teams.
Monument Group acted as global placement agent for the fund, while Latham & Watkins served as legal counsel.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.